(19)
(11) EP 3 102 576 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
19.06.2019 Bulletin 2019/25

(45) Mention of the grant of the patent:
17.04.2019 Bulletin 2019/16

(21) Application number: 15705744.9

(22) Date of filing: 30.01.2015
(51) International Patent Classification (IPC): 
C07D 471/04(2006.01)
A61P 29/00(2006.01)
 A61K 31/437(2006.01)
(86) International application number:
PCT/US2015/013699
(87) International publication number:
WO 2015/116904 (06.08.2015 Gazette 2015/31)

(54)

DIHYDROPYRROLOPYRIDINE INHIBITORS OF ROR-GAMMA

DIHYDROPYRROLOPYRIDININHIBITOREN VON ROR-GAMMA

INHIBITEURS DE ROR-GAMMA À BASE DE DIHYDROPYRROLOPYRIDINE

(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME

(30) Priority: 03.02.2014 US 201461935162 P
26.03.2014 US 201461970637 P

(43) Date of publication of application:
14.12.2016 Bulletin 2016/50

(60) Divisional application:
19166501.7

(73) Proprietor: Vitae Pharmaceuticals, LLC
Madison, NJ 07940 (US)

(72) Inventors:
  • CLAREMON, David, A.
    Maple Glen, PA 19002 (US)
  • DILLARD, Lawrence, Wayne
    Yardley, PA 19067 (US)
  • DONG, Chengguo
    Staten Island, NY 10305 (US)
  • FAN, Yi
    Doylestown, PA 18901 (US)
  • JIA, Lanqi
    Horsham, PA 19044 (US)
  • LIU, Zhijie
    Harleysville, PA 19438 (US)
  • LOTESTA, Stephen, D.
    Burlington, NJ 08016 (US)
  • MARCUS, Andrew
    Media, PA 19063 (US)
  • SINGH, Suresh, B.
    Kendall Park, NJ 08824 (US)
  • TICE, Colin, M.
    Maple Glen, PA 19002 (US)
  • YUAN, Jing
    Lansdale, PA 19446 (US)
  • ZHAO, Wei
    North Potomac, MD 20878 (US)
  • ZHENG, Yajun
    Hockessin, DE 19707 (US)
  • ZHUANG, Linghang
    Chalfont, PA 18914 (US)

(74) Representative: Potter Clarkson 
The Belgrave Centre Talbot Street
Nottingham NG1 5GG
Nottingham NG1 5GG (GB)


(56) References cited: : 
WO-A1-2004/014365
 WO-A1-2013/019682
   
       
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).